Molybdenum-99 production from reactor irradiation of molybdenum targets: A viable strategy for enhanced availability of technetium-99m

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 56, Issue 4, 2012, Pages 385-399

  Pillai, M R A ^a   Knapp, F F ^b  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b Fuel Cycle and Isotopes Division   (United States)

Author keywords

Nuclear fission; Nuclear reactors; Radionuclide generators; Technetium

Indexed keywords

ALUMINUM OXIDE; MOLYBDENUM; MOLYBDENUM 99; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; URANIUM; URANIUM 235; URANIUM 238;

COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYCLOTRON; DIAGNOSTIC IMAGING; ELECTRON ACCELERATOR; FISSION NEUTRON; GENERATOR; IRRADIATION; LOW SPECIFIC ACTIVITY; NUCLEAR ENERGY; NUCLEAR REACTOR; POSITRON EMISSION TOMOGRAPHY; QUANTUM YIELD; RADIATION DETECTION; RADIATION MEASUREMENT; RADIOACTIVE WASTE; RADIOCHEMISTRY; REACTOR DESIGN; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84869815165     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Hansell C. Nuclear medicine's double hazard-imperiled treatment and the risk of terrorism. Nonproliferation Review 2008;15:185-208.
2. Report of the Expert Review Panel on Medical Isotope Production. Presented to the Minister of Natural Resources, Canada, November 30, 2009. [cited 2012 May 3]. Available at: http://www.nrcan-rncan.gc.ca/eneene/sources/ uranuc/pdf/panrep-rapexp-eng.pdf.
3. Nuclear Science Advisory Committee Isotopes Subcommittee. Isotopes for the nation's future; a long range plan, report for the second of two 2008 charges to the Nuclear Science Advisory Committee on the Isotope Development and Production for Research and Application Program, August 27, 2009.
4. International Atomic Energy Agency (IAEA). Production and supply of molybdenum-99, Annex to the Nuclear Technology Review, 2010. Vienna: IAEA, 2010; http://www-govatom.iaea.org/Docs/GOVDOC/2010/1/EnglishOnlineVersion/NTR_2010- Attachment_7.pdf.
5. Society of Nuclear Medicine (SNM), Preliminary Draft Report of the SNM Isotope Availability Task Group. Reston, Virginia: SNM, June 2008; http://interactive.snm.org/docs/DRAFT_report_7.15.08.pdf.
6. Eckelman WC. Unparalleled contribution of technetium-99m to medicine over 5 decades. J Am Coll Cardiol Img 2009;2:364-8.
7. 99Mo supply - the times they are a-changing. Eur J Nucl Med Mol Imag 2009;36:1371-4.
8. Reliable domestic & global supplier of molybdenum-99 (Mo-99) and switch from highly enriched uranium (HEU) to low-enriched uranium (LEU) to produce Mo-99: a white paper by a coalition of professional organizations. 2009. [cited 2012 May 3]. Available at: http://hps.org/govtrelations/documents/ isotopes_white-paper_multiorganization.pdf.
9. Ramamoorthy N. Supplies of Molybdenum-99: Need for Sustainable Strategies and Enhanced International Cooperation. Nucl Med Commun 2009;30:899-905.
10. Atcher R, Appelbaum D. Solution to isotope shortage lies in domestic production. RSNA News 2010;20:9-10.
11. Service RF. Scrambling to close the isotope gap. Science 2011;331:277-9.
12. Pillai MRA, Knapp FF Jr. Overcoming the Tc-99m shortage: are options being overlooked? J Nucl Med 2011;52:15N-6N and 28N.
13. 99mTc shortage: lessons learned. In: Mazzi U, Eckelman WC, Volkert WA, editors. Technetium and other radiometals in chemistry and medicine. Padova (Padua): Serivizi Grafici Editoriali snc.; 2010. p. 445-46.
14. NRC Guidance, dated July 16, 2009, with regard to 10 CFR Part 35 Licensees, entitled, "Exemption from 10 CFR Part 32 and 10 CFR Part 35 Requirements for procurement and Transfer of Technetium-99m, and Calibration of Instrumentation Using Technetium-99m."
15. International Atomic Energy Agency (IAEA). Homogeneous aqueous solution nuclear reactors for the production of Mo-99 and other short lived radioisotopes. IAEA-TECDOC-1601. Vienna: IAEA, September 2008.
16. Nuclear News. NNSA Signs with GE Hitachi, B&W for Mo-99 Development. 2009. [cited 2012 May 3]. Available at: http://www.news-medical.net/news/ 20100128/NNSA-helps-funding-development-of-domestic-radioisotope-supply.aspx.
17. National Research Council. Medical Isotope production without highly enriched uranium. Washington, DC: National Academies Press; 2009.
18. Ruth T. Accelerating production of medical isotopes. Nature 2009;457:536-7.
19. Staples P, Chamberlin J, Lacey J, Hamilton R, Fitzgerald C, Lindemyer J et al. GTRI's effort to accelerate the establishment of a medical radioisotope production capability without the use of highly enriched uranium. In: Mazzi U, Eckelman WC, Volkert WA, editors. Technetium and other radiometals in chemistry and medicine. Padova (Padua): Serivizi Grafici Editoriali Snc.; 2010. p. 419-26.
20. 99mTc generators. Int J Rad Appl Instrum A 1991;42:643-657.
21. 99mTc: an approach to the medical isotope crisis. J Nucl Med 2010;51:13-6N.
22. 99mTc transformation. In: Mazzi U, Eckelman WC, Volkert WA, editors. Technetium and other radiometals in chemistry and medicine. Padova (Padua): Serivizi Grafici Editoriali Snc.; 2010. p. 431-4.
23. Schlyer DJ. Brookhaven National Laboratory [Personal communication].
24. Benard F, Ruth T, Meyer, T. Accelerator alternatives to producing molybdenum-99/technetium-99m. In Nathwani J, Wallace D, editors. Canada's isotope crisis: What next? Queen's Policy Study Series. Montreal and Kingston: McGill-Queen's Press; 2010. p. 95-105.
25. 99Mo. J Radioanal Nucl Chem 2003;257:195-201.
26. International Atomic Energy Agency (IAEA). Technetium-99m radiopharmaceuticals: manufacture of kits. Technical Report Series 466. Vienna: IAEA; 2008.
27. Boyd RE. Technetium-99m generators - the available options. Int J Appl Radiat Isot 1982;33:801-9. (Pubitemid 13220195)
28. 99mTc) Injection (Non-Fission), World Health Organization, International Pharmacopeia, Document QAS/08.283/Final, January 2009.
29. 99mTc-complexes of propylene amine-oxime (PnAO). Nucl Med Biol 1994;21:997-1003.
30. International Atomic Energy Agency. Operational Research Reactors in the World (December 2010). [cited 2012 May 3]. Available at: http://www-naweb.iaea. org/napc/physics/research_reactors/database/RR%20Data%20Base/datasets/ foreword_home.html.
31. Knapp FF Jr, Beets AL, Guhlke S, Zamora PO, Bender H, Palmedo H et al. Development of the alumina-based tungsten-188/rhenium-188 generator and use of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res 1997;17:1783-96.
32. Knapp FF Jr. Rhenium-188 - a generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm 1998;13:337-49.
33. Guhlke S, Beets AL, Mirzadeh S, Biersack H.-J. Knapp FF Jr. Tandem cation/anion column treatment of ammonium acetate eluants of the alumina-based tungsten-188/rhenium-188 generator: a new simple method for effective concentration of rhenium-188 perrhenate solutions. J Nucl Med 2000;41:1271-8.
34. 188Re generator. Appl Radiat Isot 2009;67:234-9.
35. Knapp FF Jr, Beets AL, Mirzadeh S, Guhlke S. Use of a New Tandem Cation/Anion Exchange System with Clinical-Scale Generators Provides High Specific Volume Solutions of Technetium-99m and Rhenium-188. In: Proceedings, International Symposium on Modern Trends in Radiopharmaceutical for Diagnosis and Therapy, sponsored by the IAEA, Lisbon, Portugal, March 30-April 3, 1988. Vienna; IAEA; p. 419-25.
36. 99mTc]Pertechnetate Eluates from Tungsten-188/Rhenium-188 or (n,γ)-Produced Molybdenum-99/Technetium-99m Generators to High Specific Volumes. J. Label. Cmpds. Radiopharm 1997;40:294-6.
37. 99mTc generator. In: Mazzi U, Eckelman WC, Volkert WA. Technetium and other radiometals in chemistry and medicine. Padova: Servici Grafici Editoriali snc.; 2010. Procedings of the International Symposium on Technetium and Other Radiometals in Chemistry and Medicine. Bressanone, Italy, September 8-11, 2010. p. 129-30.
38. 99Mo based on solvent extraction and column chromatography. Appl Radiat Isot 2010;68:1-4.
39. 99Mo based on solid-liquid extraction and column chromatography methodology. Nucl Med Biol 2010;37:17-20.
40. 99Mo. Appl Radiat Isot 1997;48:607-11.
41. 99mTc generator. J Nanosci Nanotechnol 2008;8:4447-52.
42. 188Re generator. Appl Radiat Isot 2010;68:229-38.
43. 188Re generator using a synthetic alumina. Appl Radiat Isot 2009;7-8:1162-6.
44. 99Mo. Eur J Nucl Med Mol Imag 2010:37(Suppl. 2);S251.
45. 99Mo]molybdate gel generator using an acidic alumina column for purification and concentration. Nucl Med Commun 2004;25:609-14.
46. 90Y suitable for targeted therapy. Nucl Med Biol 2008;35:245-53.
47. 188Re electrochemical generator with potential for medical applications. Radiochim Acta 2009;97:309-17.
48. 188Re. Appl Radiat Isot 2010; 68:2302-5.
49. 99Mo. Nucl Med Biol 2010;37:21-8.